Compile Data Set for Download or QSAR
Report error Found 415 Enz. Inhib. hit(s) with all data for entry = 12492
TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706571BDBM706571(US20240383915, Example 100a)
Affinity DataIC50: 0.0300nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706571BDBM706571(US20240383915, Example 100a)
Affinity DataIC50: 0.0300nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706507BDBM706507(US20240383915, Example 48)
Affinity DataIC50: 0.0400nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706612BDBM706612(US20240383915, Example 133c)
Affinity DataIC50: 0.0500nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706594BDBM706594(US20240383915, Example 119)
Affinity DataIC50: 0.0500nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706535BDBM706535(US20240383915, Example 75a)
Affinity DataIC50: 0.0500nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706551BDBM706551(US20240383915, Example 88)
Affinity DataIC50: 0.0500nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706526BDBM706526(US20240383915, Example 66a)
Affinity DataIC50: 0.0500nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706591BDBM706591(US20240383915, Example 116)
Affinity DataIC50: 0.0520nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706539BDBM706539(US20240383915, Example 78)
Affinity DataIC50: 0.0600nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706626BDBM706626(US20240383915, Example 147)
Affinity DataIC50: 0.0600nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706593BDBM706593(US20240383915, Example 118)
Affinity DataIC50: 0.0600nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706609BDBM706609(US20240383915, Example 130a)
Affinity DataIC50: 0.0600nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706573BDBM706573(US20240383915, Example 101)
Affinity DataIC50: 0.0600nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706582BDBM706582(US20240383915, Example 108a)
Affinity DataIC50: 0.0600nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706573BDBM706573(US20240383915, Example 101)
Affinity DataIC50: 0.0620nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706556BDBM706556(US20240383915, Example 92a)
Affinity DataIC50: 0.0650nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706535BDBM706535(US20240383915, Example 75a)
Affinity DataIC50: 0.0660nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706542BDBM706542(US20240383915, Example 81)
Affinity DataIC50: 0.0660nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706542BDBM706542(US20240383915, Example 81)
Affinity DataIC50: 0.0670nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706604BDBM706604(US20240383915, Example 127)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706562BDBM706562(US20240383915, Example 94)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706595BDBM706595(US20240383915, Example 120a)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706561BDBM706561(US20240383915, Example 93d)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706569BDBM706569(US20240383915, Example 99a)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706609BDBM706609(US20240383915, Example 130a)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706560BDBM706560(US20240383915, Example 93c)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706616BDBM706616(US20240383915, Example 137)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706556BDBM706556(US20240383915, Example 92a)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706597BDBM706597(US20240383915, Example 121)
Affinity DataIC50: 0.0700nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706591BDBM706591(US20240383915, Example 116)
Affinity DataIC50: 0.0740nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706570BDBM706570(US20240383915, Example 99b)
Affinity DataIC50: 0.0750nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706552BDBM706552(US20240383915, Example 89)
Affinity DataIC50: 0.0750nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706596BDBM706596(US20240383915, Example 120b)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706570BDBM706570(US20240383915, Example 99b)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706579BDBM706579(US20240383915, Example 105a)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706618BDBM706618(US20240383915, Example 139)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706592BDBM706592(US20240383915, Example 117)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706566BDBM706566(US20240383915, Example 97)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706647BDBM706647(US20240383915, Example 175)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706565BDBM706565(US20240383915, Example 96)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706614BDBM706614(US20240383915, Example 135)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706613BDBM706613(US20240383915, Example 134)
Affinity DataIC50: 0.0800nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706561BDBM706561(US20240383915, Example 93d)
Affinity DataIC50: 0.0850nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706549BDBM706549(US20240383915, Example 87a)
Affinity DataIC50: 0.0870nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706550BDBM706550(US20240383915, Example 87b)
Affinity DataIC50: 0.0890nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas(Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706604BDBM706604(US20240383915, Example 127)
Affinity DataIC50: 0.0890nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706547BDBM706547(US20240383915, Example 85)
Affinity DataIC50: 0.0900nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706563BDBM706563(US20240383915, Example 95a)
Affinity DataIC50: 0.0900nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

TargetGTPase KRas [G12V](Human)
Genentech

US Patent
LigandChemical structure of BindingDB Monomer ID 706587BDBM706587(US20240383915, Example 113a)
Affinity DataIC50: 0.0900nMAssay Description:KRAS Biochemical Assay—BODIPY-GDP Exchange TR-FRET. Biochemical compound potencies were assessed by evaluating inhibition of SOS1-mediated nucleotide...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/12/2025
Entry Details
US Patent

Displayed 1 to 50 (of 415 total ) | Next | Last >>
Jump to: